Evidence map›Paper›PMID 40007845›Full record

ArticleEFSA journal. European Food Safety Authority2016

Priority topics for the development of risk assessment guidance by EFSA's Scientific Committee in 2016-2018.

EFSA Scientific Committee

Abstract read
In one paragraph

Article in EFSA journal. European Food Safety Authority, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

EFSA Scientific Committee

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

EFSA asked its Scientific Committee to review its own cross-cutting guidance for scientific assessments in order to identify gaps requiring either new or the revision of existing guidance. Through strategic discussions, the Scientific Committee identified topics to be included in its 2016-2018 work programme without ranking their priority. Three topics were identified for activity leading to the development of new guidance: individual susceptibility and uncertainty factors; interpretation of epidemiological studies; history of use. These will be further discussed and introduced into the rolling work programme as time and resources become available. Work is already underway in three areas which will lead to new or revised cross-cutting guidance: chemical mixtures; follow up on the Threshold of Toxicological Concern approach; nanotechnologies. The Scientific Committee will continue to keep priorities for cross-cutting guidance across EFSA's fields of responsibility under review.

Indexed as

guidance documentrisk assessment

Identifiers

PMID40007845
PMCPMC11847968

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.